Acadia Healthcare Investors: Legal Action Unveiled
Glancy Prongay & Murray LLP, a prominent law firm specializing in shareholder rights, has announced the commencement of a class action lawsuit representing investors of Acadia Healthcare Company Inc. (NASDAQ: ACHC). This significant move comes in response to allegations concerning the company's business practices during a defined Class Period, which spans from February 28, 2020, to September 26, 2024.
Understanding the Class Action
What Led to the Lawsuit?
The lawsuit targets investors who acquired Acadia's securities during the specified Class Period. Investors are given a deadline of December 16, 2024, to file a motion to be appointed as lead plaintiffs in the case. This filing follows troubling reports about Acadia’s practices in its facilities that have raised significant alarm among the public and governing bodies.
Allegations Against Acadia
Recent accusations include claims from reputable news sources indicating that Acadia has engaged in potentially illegal practices. Reports suggest that the company has been luring patients and detaining them under questionable circumstances. Specifically, it has been alleged that this was done even when such detentions were not medically warranted, leading to a serious inquiry from authorities across multiple states.
The Impacts of Recent News on Investors
Stock Price Reactions
On September 1, 2024, alarming revelations led to Acadia’s stock price declining by $3.72, representing a 4.5% drop, to close at $78.21 on September 3, 2024. This shift significantly impacted investors, stirring unease in the market and prompting questions about the company’s operational integrity.
Further Investigations and Market Response
A subsequent report on September 27, 2024, revealed that Acadia received formal requests for data from the U.S. Attorney’s Office. These inquiries expand into critical operational aspects such as admissions processes and billing practices. In the wake of this news, Acadia’s stock took another hit, dropping $12.38, or 16.36%, to close at $63.28 on that same day, heightening concerns among shareholders.
Details of Investor Rights
What Should Affected Investors Do?
Investors who believe they have suffered losses due to these events are encouraged to seek legal recourse. GPM emphasizes the importance of understanding one's rights and the potential for recovery through informed legal action. Those interested can explore their options regarding leading this class action or simply retaining their status as class members without further action.
Contact Information
For inquiries or additional information regarding the class action lawsuit, investors can contact Charles H. Linehan at Glancy Prongay & Murray LLP. GPM specializes in protecting investor interests and navigating the complexities of class action litigation.
Frequently Asked Questions
What is the class action lawsuit about?
The lawsuit involves claims against Acadia Healthcare regarding its business practices that allegedly violated laws related to patient admissions and detentions.
How can investors participate in the class action?
Investors who acquired Acadia’s securities during the defined Class Period can file a motion by December 16, 2024, to be appointed as lead plaintiffs.
What were the implications of the recent news articles about Acadia?
Recent reports raised serious concerns about Acadia's practices, causing significant drops in its stock price and leading to investigations.
How much did Acadia's stock price fall after the allegations surfaced?
After the allegations surfaced, Acadia's stock fell by considerable amounts, including a 4.5% drop initially, followed by a 16.36% decline.
Where can investors find more information?
Investors can reach out directly to GPM or visit their website for further details and support regarding the ongoing class action lawsuit.
